{"transactions":[{"id":4618838,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24047,"kind":"person","name":"Duprey Lauren Rusckowski","position":1,"cik":"0001977746","reported_name":"Duprey Lauren Rusckowski","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Transformation Officer"}}],"security":"American Depositary Shares","published_at":"2026-09-16T01:12:46.000Z","date":"2026-09-14","kind":"sale","planned":false,"acquired":false,"shares":34535,"price":18.54,"value":640278.9,"ownership":{"direct":true},"balance_after":191522,"source":{"system":"sec-edgar","filing":"0001395064-26-000340","document":"wk-form4_1789521164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1977746/000139506426000340/wk-form4_1789521164.xml","form_type":"4"}},{"id":4064,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-09-04T01:49:19.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":116191,"price":18.49,"value":2148371.59,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026."}],"balance_after":145465,"source":{"system":"sec-edgar","filing":"0001395064-26-000335","document":"wk-form4_1788486556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1977689/000139506426000335/wk-form4_1788486556.xml","form_type":"4"}},{"id":678593,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-08-21T20:30:13.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":19651,"price":18.49,"value":363346.99,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026."}],"balance_after":261656,"source":{"system":"sec-edgar","filing":"0001493152-26-039693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226039693/ownership.xml","form_type":"4"}},{"id":681102,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":21564,"kind":"person","name":"Greenway Nicola Deidre Petal","position":1,"cik":"0002123546","reported_name":"Greenway Nicola Deidre Petal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"American Depositary Shares","published_at":"2026-08-19T20:15:29.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":12980,"price":18.1139,"value":235118.422,"ownership":{"direct":true},"balance_after":40049,"source":{"system":"sec-edgar","filing":"0001493152-26-039214","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226039214/ownership.xml","form_type":"4"}},{"id":689043,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24050,"kind":"person","name":"Farajallah Awny Samaan Botros","position":1,"cik":"0002121389","reported_name":"Farajallah Awny Samaan Botros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:54:07.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":14006,"price":17.1,"value":239502.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":116177,"source":{"system":"sec-edgar","filing":"0001493152-26-037515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037515/ownership.xml","form_type":"4"}},{"id":689042,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24049,"kind":"person","name":"Ibrahim Ramy Riad Ahmed","position":1,"cik":"0002121395","reported_name":"Ibrahim Ramy Riad Ahmed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, PDT BU"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:53:45.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":7277,"price":17.1,"value":124436.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":102588,"source":{"system":"sec-edgar","filing":"0001493152-26-037514","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037514/ownership.xml","form_type":"4"}},{"id":689041,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24048,"kind":"person","name":"Pacheco Rhonda Janice","position":1,"cik":"0002111489","reported_name":"Pacheco Rhonda Janice","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, U.S. Business Unit"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:53:37.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":16901,"price":17.1,"value":289007.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":182507,"source":{"system":"sec-edgar","filing":"0001493152-26-037513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037513/ownership.xml","form_type":"4"}},{"id":689040,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24047,"kind":"person","name":"Duprey Lauren Rusckowski","position":1,"cik":"0001977746","reported_name":"Duprey Lauren Rusckowski","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Transformation Officer"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:51:23.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":47586,"price":17.1,"value":813720.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":226057,"source":{"system":"sec-edgar","filing":"0001493152-26-037509","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037509/ownership.xml","form_type":"4"}},{"id":689039,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:50:30.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":165393,"price":17.1,"value":2828220.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":766569,"source":{"system":"sec-edgar","filing":"0001493152-26-037507","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037507/ownership.xml","form_type":"4"}},{"id":689038,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24046,"kind":"person","name":"Pignagnoli Agosti Marcello","position":1,"cik":"0001977817","reported_name":"Pignagnoli Agosti Marcello","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head, Strat. & Port. Dev"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:46:59.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":22957,"price":17.1,"value":392564.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":176977,"source":{"system":"sec-edgar","filing":"0001493152-26-037505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037505/ownership.xml","form_type":"4"}},{"id":689037,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24045,"kind":"person","name":"Bitetti Teresa Marie","position":1,"cik":"0001977608","reported_name":"Bitetti Teresa Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, OBU"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:45:10.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":50012,"price":17.1,"value":855205.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":252010,"source":{"system":"sec-edgar","filing":"0001493152-26-037502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037502/ownership.xml","form_type":"4"}},{"id":689459,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24210,"kind":"person","name":"Shannon Elaine Mary","position":1,"cik":"0002009368","reported_name":"Shannon Elaine Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Global Supply & Quality"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:42:38.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":3978,"price":17.1,"value":68023.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total in Column 5 represents the amount of American Depositary Shares held by the Reporting Person as of the date of this filing."}],"balance_after":63333,"source":{"system":"sec-edgar","filing":"0001493152-26-037499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009368/000149315226037499/ownership.xml","form_type":"4"}},{"id":689036,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24044,"kind":"person","name":"Ricci Gabriele","position":1,"cik":"0001977815","reported_name":"Ricci Gabriele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Data & Tech. Officer"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:39:20.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":25088,"price":17.1,"value":429004.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":171654,"source":{"system":"sec-edgar","filing":"0001493152-26-037494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037494/ownership.xml","form_type":"4"}},{"id":689035,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":21564,"kind":"person","name":"Greenway Nicola Deidre Petal","position":1,"cik":"0002123546","reported_name":"Greenway Nicola Deidre Petal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:28:54.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":6774,"price":17.1,"value":115835.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total in Column 5 represents the amount of American Depositary Shares held by the Reporting Person as of the date of this filing."}],"balance_after":53029,"source":{"system":"sec-edgar","filing":"0001493152-26-037486","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037486/ownership.xml","form_type":"4"}},{"id":689034,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:27:05.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":89090,"price":17.1,"value":1523439.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":391489,"source":{"system":"sec-edgar","filing":"0001493152-26-037484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037484/ownership.xml","form_type":"4"}},{"id":689033,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24042,"kind":"person","name":"Platford Giles Richard","position":1,"cik":"0001977620","reported_name":"Platford Giles Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, IBU"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:25:22.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":31083,"price":17.1,"value":531519.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":315838,"source":{"system":"sec-edgar","filing":"0001493152-26-037482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037482/ownership.xml","form_type":"4"}},{"id":689032,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24041,"kind":"person","name":"Furney Natalie Anne Marie","position":1,"cik":"0002111535","reported_name":"Furney Natalie Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global General Counsel"}}],"security":"American Depositary Shares","published_at":"2026-08-13T01:23:26.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":30868,"price":17.1,"value":527842.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a mandatory sale to cover taxes associated with the vesting of equity awards held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":204298,"source":{"system":"sec-edgar","filing":"0001493152-26-037480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037480/ownership.xml","form_type":"4"}},{"id":689458,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24210,"kind":"person","name":"Shannon Elaine Mary","position":1,"cik":"0002009368","reported_name":"Shannon Elaine Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Global Supply & Quality"}}],"security":"American Depositary Shares","published_at":"2026-08-12T20:10:02.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":20363,"price":17.55,"value":357370.65,"ownership":{"direct":true},"balance_after":67311,"source":{"system":"sec-edgar","filing":"0001493152-26-037352","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009368/000149315226037352/ownership.xml","form_type":"4"}},{"id":689029,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":21564,"kind":"person","name":"Greenway Nicola Deidre Petal","position":1,"cik":"0002123546","reported_name":"Greenway Nicola Deidre Petal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"American Depositary Shares","published_at":"2026-08-12T20:10:01.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":33628,"price":17.5067,"value":588715.3076,"ownership":{"direct":true},"balance_after":59803,"source":{"system":"sec-edgar","filing":"0001493152-26-037351","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037351/ownership.xml","form_type":"4"}},{"id":689028,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":21564,"kind":"person","name":"Greenway Nicola Deidre Petal","position":1,"cik":"0002123546","reported_name":"Greenway Nicola Deidre Petal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"American Depositary Shares","published_at":"2026-08-12T20:10:01.000Z","date":"2026-08-10","kind":"sale","planned":false,"acquired":false,"shares":975,"price":17.5,"value":17062.5,"ownership":{"direct":true},"balance_after":93431,"source":{"system":"sec-edgar","filing":"0001493152-26-037351","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000149315226037351/ownership.xml","form_type":"4"}},{"id":714855,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":1,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:29:03.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1319,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1319},"source":{"system":"sec-edgar","filing":"0001395064-26-000276","document":"wk-form4_1783376940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000139506426000276/wk-form4_1783376940.xml","form_type":"4"}},{"id":714854,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":1,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:29:03.000Z","date":"2026-07-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1152,"price":4931.2,"value":5680742.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"date","element":"transactionDate","label":"F3","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":1152},"source":{"system":"sec-edgar","filing":"0001395064-26-000276","document":"wk-form4_1783376940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000139506426000276/wk-form4_1783376940.xml","form_type":"4"}},{"id":714853,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":1,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:29:03.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American\nDepositary Shares following vest. The RSUs vest on June 1, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the conversion of 3,100 Ordinary Shares into 6,200 American Depositary Shares upon vesting of RSUs."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001395064-26-000276","document":"wk-form4_1783376940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000139506426000276/wk-form4_1783376940.xml","form_type":"4"}},{"id":715691,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32216,"kind":"person","name":"MARAGANORE JOHN","position":1,"cik":"0001180432","reported_name":"MARAGANORE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:28:41.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1319,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1319},"source":{"system":"sec-edgar","filing":"0001395064-26-000275","document":"wk-form4_1783376919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180432/000139506426000275/wk-form4_1783376919.xml","form_type":"4"}},{"id":715690,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32216,"kind":"person","name":"MARAGANORE JOHN","position":1,"cik":"0001180432","reported_name":"MARAGANORE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:28:41.000Z","date":"2026-07-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1152,"price":4931.2,"value":5680742.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"date","element":"transactionDate","label":"F3","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":1152},"source":{"system":"sec-edgar","filing":"0001395064-26-000275","document":"wk-form4_1783376919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180432/000139506426000275/wk-form4_1783376919.xml","form_type":"4"}},{"id":715689,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32216,"kind":"person","name":"MARAGANORE JOHN","position":1,"cik":"0001180432","reported_name":"MARAGANORE JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:28:41.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American\nDepositary Shares following vest. The RSUs vest on June 1, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the conversion of 3,100 Ordinary Shares into 6,200 American Depositary Shares upon vesting of RSUs."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001395064-26-000275","document":"wk-form4_1783376919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180432/000139506426000275/wk-form4_1783376919.xml","form_type":"4"}},{"id":714623,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32036,"kind":"person","name":"Reed Kimberly A.","position":1,"cik":"0001873931","reported_name":"Reed Kimberly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:28:22.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1319,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1319},"source":{"system":"sec-edgar","filing":"0001395064-26-000274","document":"wk-form4_1783376900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000274/wk-form4_1783376900.xml","form_type":"4"}},{"id":714622,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32036,"kind":"person","name":"Reed Kimberly A.","position":1,"cik":"0001873931","reported_name":"Reed Kimberly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:28:22.000Z","date":"2026-07-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1152,"price":4931.2,"value":5680742.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"date","element":"transactionDate","label":"F3","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":1152},"source":{"system":"sec-edgar","filing":"0001395064-26-000274","document":"wk-form4_1783376900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000274/wk-form4_1783376900.xml","form_type":"4"}},{"id":714621,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32036,"kind":"person","name":"Reed Kimberly A.","position":1,"cik":"0001873931","reported_name":"Reed Kimberly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:28:22.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American\nDepositary Shares following vest. The RSUs vest on June 1, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the conversion of 3,100 Ordinary Shares into 6,200 American Depositary Shares upon vesting of RSUs."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001395064-26-000274","document":"wk-form4_1783376900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000274/wk-form4_1783376900.xml","form_type":"4"}},{"id":714619,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32034,"kind":"person","name":"Iijima Masami","position":1,"cik":"0002114485","reported_name":"Iijima Masami","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:14:02.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1937,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1937},"source":{"system":"sec-edgar","filing":"0001395064-26-000270","document":"wk-form4_1783376039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000270/wk-form4_1783376039.xml","form_type":"4"}},{"id":714618,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32034,"kind":"person","name":"Iijima Masami","position":1,"cik":"0002114485","reported_name":"Iijima Masami","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:14:02.000Z","date":"2026-07-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2152,"price":4931.2,"value":10611942.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"date","element":"transactionDate","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":2152},"source":{"system":"sec-edgar","filing":"0001395064-26-000270","document":"wk-form4_1783376039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000270/wk-form4_1783376039.xml","form_type":"4"}},{"id":714617,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32034,"kind":"person","name":"Iijima Masami","position":1,"cik":"0002114485","reported_name":"Iijima Masami","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:14:02.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029."}],"balance_after":14601,"source":{"system":"sec-edgar","filing":"0001395064-26-000270","document":"wk-form4_1783376039.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000270/wk-form4_1783376039.xml","form_type":"4"}},{"id":714824,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":22638,"kind":"person","name":"BROUSSARD BRUCE D","position":1,"cik":"0001185643","reported_name":"BROUSSARD BRUCE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:12:00.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1319,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1319},"source":{"system":"sec-edgar","filing":"0001395064-26-000268","document":"wk-form4_1783375918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185643/000139506426000268/wk-form4_1783375918.xml","form_type":"4"}},{"id":714823,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":22638,"kind":"person","name":"BROUSSARD BRUCE D","position":1,"cik":"0001185643","reported_name":"BROUSSARD BRUCE D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:12:00.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American\nDepositary Shares following vest. The RSUs vest on June 1, 2029."}],"balance_after":4595,"source":{"system":"sec-edgar","filing":"0001395064-26-000268","document":"wk-form4_1783375918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185643/000139506426000268/wk-form4_1783375918.xml","form_type":"4"}},{"id":714616,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":11803,"kind":"person","name":"Stoffels Paulus","position":1,"cik":"0001559387","reported_name":"Stoffels Paulus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:11:16.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1307,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1307},"source":{"system":"sec-edgar","filing":"0001395064-26-000266","document":"wk-form4_1783375873.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000266/wk-form4_1783375873.xml","form_type":"4"}},{"id":714615,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":11803,"kind":"person","name":"Stoffels Paulus","position":1,"cik":"0001559387","reported_name":"Stoffels Paulus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:11:16.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American\nDepositary Shares following vest. The RSUs vest on June 1, 2029."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001395064-26-000266","document":"wk-form4_1783375873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000266/wk-form4_1783375873.xml","form_type":"4"}},{"id":714614,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32029,"kind":"person","name":"Kimura Koichiro","position":1,"cik":"0002137620","reported_name":"Kimura Koichiro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:10:35.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1937,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1937},"source":{"system":"sec-edgar","filing":"0001395064-26-000264","document":"wk-form4_1783375832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000264/wk-form4_1783375832.xml","form_type":"4"}},{"id":714613,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32029,"kind":"person","name":"Kimura Koichiro","position":1,"cik":"0002137620","reported_name":"Kimura Koichiro","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:10:35.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001395064-26-000264","document":"wk-form4_1783375832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000264/wk-form4_1783375832.xml","form_type":"4"}},{"id":714612,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32033,"kind":"person","name":"Tsusaka Miki","position":1,"cik":"0002113695","reported_name":"Tsusaka Miki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:10:06.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1937,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":1937},"source":{"system":"sec-edgar","filing":"0001395064-26-000263","document":"wk-form4_1783375803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000263/wk-form4_1783375803.xml","form_type":"4"}},{"id":714611,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32033,"kind":"person","name":"Tsusaka Miki","position":1,"cik":"0002113695","reported_name":"Tsusaka Miki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:10:06.000Z","date":"2026-07-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2152,"price":4931.2,"value":10611942.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"date","element":"transactionDate","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":2152},"source":{"system":"sec-edgar","filing":"0001395064-26-000263","document":"wk-form4_1783375803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000263/wk-form4_1783375803.xml","form_type":"4"}},{"id":714610,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32033,"kind":"person","name":"Tsusaka Miki","position":1,"cik":"0002113695","reported_name":"Tsusaka Miki","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:10:06.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029."}],"balance_after":8200,"source":{"system":"sec-edgar","filing":"0001395064-26-000263","document":"wk-form4_1783375803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000263/wk-form4_1783375803.xml","form_type":"4"}},{"id":714609,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32032,"kind":"person","name":"Miyabashira Asuka","position":1,"cik":"0002111457","reported_name":"Miyabashira Asuka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Japan Pharma B.U."}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:28.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":666,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":666},"source":{"system":"sec-edgar","filing":"0001395064-26-000261","document":"wk-form4_1783375765.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000261/wk-form4_1783375765.xml","form_type":"4"}},{"id":714608,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32032,"kind":"person","name":"Miyabashira Asuka","position":1,"cik":"0002111457","reported_name":"Miyabashira Asuka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Japan Pharma B.U."}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:28.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1174,"derivative":{"exercise_date":"2028-06-01","expiration_date":"2028-06-01","underlying":"Ordinary Shares","underlying_shares":664},"source":{"system":"sec-edgar","filing":"0001395064-26-000261","document":"wk-form4_1783375765.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000261/wk-form4_1783375765.xml","form_type":"4"}},{"id":714607,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32032,"kind":"person","name":"Miyabashira Asuka","position":1,"cik":"0002111457","reported_name":"Miyabashira Asuka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Japan Pharma B.U."}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:28.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":1392,"derivative":{"exercise_date":"2027-06-01","expiration_date":"2027-06-01","underlying":"Ordinary Shares","underlying_shares":664},"source":{"system":"sec-edgar","filing":"0001395064-26-000261","document":"wk-form4_1783375765.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000261/wk-form4_1783375765.xml","form_type":"4"}},{"id":714606,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32032,"kind":"person","name":"Miyabashira Asuka","position":1,"cik":"0002111457","reported_name":"Miyabashira Asuka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Japan Pharma B.U."}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:28.000Z","date":"2026-07-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1022,"price":4931.4,"value":5039890.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"date","element":"transactionDate","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":1022},"source":{"system":"sec-edgar","filing":"0001395064-26-000261","document":"wk-form4_1783375765.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000261/wk-form4_1783375765.xml","form_type":"4"}},{"id":714605,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32032,"kind":"person","name":"Miyabashira Asuka","position":1,"cik":"0002111457","reported_name":"Miyabashira Asuka","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Japan Pharma B.U."}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:09:28.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027."}],"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001395064-26-000261","document":"wk-form4_1783375765.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000261/wk-form4_1783375765.xml","form_type":"4"}},{"id":714604,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32031,"kind":"person","name":"Furuta Milano","position":1,"cik":"0002111400","reported_name":"Furuta Milano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:03.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":4288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":4288,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":4288},"source":{"system":"sec-edgar","filing":"0001395064-26-000260","document":"wk-form4_1783375740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000260/wk-form4_1783375740.xml","form_type":"4"}},{"id":714603,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32031,"kind":"person","name":"Furuta Milano","position":1,"cik":"0002111400","reported_name":"Furuta Milano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:03.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":4288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":8482,"derivative":{"exercise_date":"2028-06-01","expiration_date":"2028-06-01","underlying":"Ordinary Shares","underlying_shares":4288},"source":{"system":"sec-edgar","filing":"0001395064-26-000260","document":"wk-form4_1783375740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000260/wk-form4_1783375740.xml","form_type":"4"}},{"id":714602,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32031,"kind":"person","name":"Furuta Milano","position":1,"cik":"0002111400","reported_name":"Furuta Milano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:03.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":4288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":11741,"derivative":{"exercise_date":"2027-06-01","expiration_date":"2027-06-01","underlying":"Ordinary Shares","underlying_shares":4288},"source":{"system":"sec-edgar","filing":"0001395064-26-000260","document":"wk-form4_1783375740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000260/wk-form4_1783375740.xml","form_type":"4"}},{"id":714601,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32031,"kind":"person","name":"Furuta Milano","position":1,"cik":"0002111400","reported_name":"Furuta Milano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:09:03.000Z","date":"2026-07-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16619,"price":4931.5,"value":81956598.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"date","element":"transactionDate","label":"F2","text":"Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":16619},"source":{"system":"sec-edgar","filing":"0001395064-26-000260","document":"wk-form4_1783375740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000260/wk-form4_1783375740.xml","form_type":"4"}},{"id":714600,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32031,"kind":"person","name":"Furuta Milano","position":1,"cik":"0002111400","reported_name":"Furuta Milano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:09:03.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027."}],"balance_after":70200,"source":{"system":"sec-edgar","filing":"0001395064-26-000260","document":"wk-form4_1783375740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000260/wk-form4_1783375740.xml","form_type":"4"}},{"id":714599,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24042,"kind":"person","name":"Platford Giles Richard","position":1,"cik":"0001977620","reported_name":"Platford Giles Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, IBU"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:08:23.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":49558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":346921,"source":{"system":"sec-edgar","filing":"0001395064-26-000258","document":"wk-form4_1783375700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000258/wk-form4_1783375700.xml","form_type":"4"}},{"id":714598,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32030,"kind":"person","name":"Smoter Jennifer Marie","position":1,"cik":"0002131280","reported_name":"Smoter Jennifer Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm. & Gov.  Officer"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:07:54.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":18808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":18808,"source":{"system":"sec-edgar","filing":"0001395064-26-000257","document":"wk-form4_1783375672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000257/wk-form4_1783375672.xml","form_type":"4"}},{"id":714597,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24049,"kind":"person","name":"Ibrahim Ramy Riad Ahmed","position":1,"cik":"0002121395","reported_name":"Ibrahim Ramy Riad Ahmed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, PDT BU"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:07:27.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":25078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":109865,"source":{"system":"sec-edgar","filing":"0001395064-26-000256","document":"wk-form4_1783375644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000256/wk-form4_1783375644.xml","form_type":"4"}},{"id":714596,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":21564,"kind":"person","name":"Greenway Nicola Deidre Petal","position":1,"cik":"0002123546","reported_name":"Greenway Nicola Deidre Petal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Human Resources Officer"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:06:33.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":22570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":94406,"source":{"system":"sec-edgar","filing":"0001395064-26-000255","document":"wk-form4_1783375590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000255/wk-form4_1783375590.xml","form_type":"4"}},{"id":714595,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24050,"kind":"person","name":"Farajallah Awny Samaan Botros","position":1,"cik":"0002121389","reported_name":"Farajallah Awny Samaan Botros","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:06:05.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":17554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":130183,"source":{"system":"sec-edgar","filing":"0001395064-26-000254","document":"wk-form4_1783375562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000254/wk-form4_1783375562.xml","form_type":"4"}},{"id":714594,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24041,"kind":"person","name":"Furney Natalie Anne Marie","position":1,"cik":"0002111535","reported_name":"Furney Natalie Anne Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global General Counsel"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:05:30.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":43886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":235166,"source":{"system":"sec-edgar","filing":"0001395064-26-000253","document":"wk-form4_1783375528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000253/wk-form4_1783375528.xml","form_type":"4"}},{"id":714593,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24048,"kind":"person","name":"Pacheco Rhonda Janice","position":1,"cik":"0002111489","reported_name":"Pacheco Rhonda Janice","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, U.S. Business Unit"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:05:08.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":199408,"source":{"system":"sec-edgar","filing":"0001395064-26-000252","document":"wk-form4_1783375506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000252/wk-form4_1783375506.xml","form_type":"4"}},{"id":714592,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24046,"kind":"person","name":"Pignagnoli Agosti Marcello","position":1,"cik":"0001977817","reported_name":"Pignagnoli Agosti Marcello","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head, Strat. & Port. Dev."}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:04:42.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":27586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":199934,"source":{"system":"sec-edgar","filing":"0001395064-26-000251","document":"wk-form4_1783375479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000251/wk-form4_1783375479.xml","form_type":"4"}},{"id":714591,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24044,"kind":"person","name":"Ricci Gabriele","position":1,"cik":"0001977815","reported_name":"Ricci Gabriele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Data & Tech. Officer"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:04:18.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":37616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":196742,"source":{"system":"sec-edgar","filing":"0001395064-26-000250","document":"wk-form4_1783375456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000250/wk-form4_1783375456.xml","form_type":"4"}},{"id":715694,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24210,"kind":"person","name":"Shannon Elaine Mary","position":1,"cik":"0002009368","reported_name":"Shannon Elaine Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres., Global Supply & Quality"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:03:45.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":30094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":87674,"source":{"system":"sec-edgar","filing":"0001395064-26-000249","document":"wk-form4_1783375422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009368/000139506426000249/wk-form4_1783375422.xml","form_type":"4"}},{"id":714590,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24047,"kind":"person","name":"Duprey Lauren Rusckowski","position":1,"cik":"0001977746","reported_name":"Duprey Lauren Rusckowski","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Transformation Officer"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:03:05.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":45140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":273643,"source":{"system":"sec-edgar","filing":"0001395064-26-000248","document":"wk-form4_1783375382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000248/wk-form4_1783375382.xml","form_type":"4"}},{"id":714589,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24045,"kind":"person","name":"Bitetti Teresa Marie","position":1,"cik":"0001977608","reported_name":"Bitetti Teresa Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, OBU"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:02:36.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":43886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":302022,"source":{"system":"sec-edgar","filing":"0001395064-26-000247","document":"wk-form4_1783375354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000247/wk-form4_1783375354.xml","form_type":"4"}},{"id":714588,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7743,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":7743,"derivative":{"exercise_date":"2029-06-01","expiration_date":"2029-06-01","underlying":"Ordinary Shares","underlying_shares":7743},"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714587,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":7741,"derivative":{"exercise_date":"2028-06-01","expiration_date":"2028-06-01","underlying":"Ordinary Shares","underlying_shares":7741},"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714586,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Tax Obligation Award","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":7741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":7741,"derivative":{"exercise_date":"2027-06-01","expiration_date":"2027-06-01","underlying":"Ordinary Shares","underlying_shares":7741},"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714585,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":22800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027."}],"balance_after":22800,"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714584,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:02:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":480579,"source":{"system":"sec-edgar","filing":"0001395064-26-000246","document":"wk-form4_1783375318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000246/wk-form4_1783375318.xml","form_type":"4"}},{"id":714583,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-07-06T22:01:15.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":125390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027."}],"balance_after":931962,"source":{"system":"sec-edgar","filing":"0001395064-26-000244","document":"wk-form4_1783375271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000244/wk-form4_1783375271.xml","form_type":"4"}},{"id":798968,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":48489,"kind":"person","name":"Weber Christophe Pierre","position":1,"cik":"0002011270","reported_name":"Weber Christophe Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Tax Obligation Award","published_at":"2026-04-28T10:08:54.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":78978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":125345,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":78978},"source":{"system":"sec-edgar","filing":"0001395064-26-000140","document":"wk-form4_1777370932.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2011270/000139506426000140/wk-form4_1777370932.xml","form_type":"4"}},{"id":798967,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":48489,"kind":"person","name":"Weber Christophe Pierre","position":1,"cik":"0002011270","reported_name":"Weber Christophe Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:08:54.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":165370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 369,378 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (261,114 shares), July 1, 2027 (72,384 shares) and July 1, 2028 (35,850 shares)."}],"balance_after":418803,"source":{"system":"sec-edgar","filing":"0001395064-26-000140","document":"wk-form4_1777370932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2011270/000139506426000140/wk-form4_1777370932.xml","form_type":"4"}},{"id":798966,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":48489,"kind":"person","name":"Weber Christophe Pierre","position":1,"cik":"0002011270","reported_name":"Weber Christophe Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2026-04-28T10:08:54.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":78900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of ordinary shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026 the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 174,900 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one Ordinary Share.  The RSUs vest on the following schedule: June 1, 2026 (125,000 shares), June 1, 2027 (32,700 shares) and June 1, 2028 (17,200 shares)."}],"balance_after":1014200,"source":{"system":"sec-edgar","filing":"0001395064-26-000140","document":"wk-form4_1777370932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011270/000139506426000140/wk-form4_1777370932.xml","form_type":"4"}},{"id":798715,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32031,"kind":"person","name":"Furuta Milano","position":1,"cik":"0002111400","reported_name":"Furuta Milano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Tax Obligation Award","published_at":"2026-04-28T10:08:00.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":7814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares."}],"balance_after":16619,"derivative":{"exercise_date":"2026-06-01","expiration_date":"2026-06-01","underlying":"Ordinary Shares","underlying_shares":7814},"source":{"system":"sec-edgar","filing":"0001395064-26-000138","document":"wk-form4_1777370878.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000138/wk-form4_1777370878.xml","form_type":"4"}},{"id":798714,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":32031,"kind":"person","name":"Furuta Milano","position":1,"cik":"0002111400","reported_name":"Furuta Milano","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-28T10:08:00.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of ordinary shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 27,300 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one Ordinary Share.  The RSUs vest on the following schedule: June 1, 2026 (16,200 shares), June 1, 2027 (7,100 shares) and June 1, 2028 (4000 shares)."}],"balance_after":57900,"source":{"system":"sec-edgar","filing":"0001395064-26-000138","document":"wk-form4_1777370878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000138/wk-form4_1777370878.xml","form_type":"4"}},{"id":798713,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":2663,"kind":"person","name":"Plump Andrew Stewart","position":1,"cik":"0001977689","reported_name":"Plump Andrew Stewart","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:07:30.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":212470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 464.432 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (329,478 shares), July 1, 2027 (91,580 shares) and July 1, 2028 (43,374 shares)."}],"balance_after":806572,"source":{"system":"sec-edgar","filing":"0001395064-26-000136","document":"wk-form4_1777370848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000136/wk-form4_1777370848.xml","form_type":"4"}},{"id":798712,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24044,"kind":"person","name":"Ricci Gabriele","position":1,"cik":"0001977815","reported_name":"Ricci Gabriele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Data & Tech. Officer"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:06:39.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":34994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 80,768 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (56,946 shares), July 1, 2027 (16,012 shares) and July 1, 2028 (7,810 shares)."}],"balance_after":159126,"source":{"system":"sec-edgar","filing":"0001395064-26-000134","document":"wk-form4_1777370797.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000134/wk-form4_1777370797.xml","form_type":"4"}},{"id":798711,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24045,"kind":"person","name":"Bitetti Teresa Marie","position":1,"cik":"0001977608","reported_name":"Bitetti Teresa Marie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, OBU"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:06:08.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":64988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 150,790 restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (105,044 shares), July 1, 2027 (30,564 shares) and July 1, 2028 (15,182 shares)."}],"balance_after":258136,"source":{"system":"sec-edgar","filing":"0001395064-26-000132","document":"wk-form4_1777370765.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000132/wk-form4_1777370765.xml","form_type":"4"}},{"id":798710,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24047,"kind":"person","name":"Duprey Lauren Rusckowski","position":1,"cik":"0001977746","reported_name":"Duprey Lauren Rusckowski","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Transformation Officer"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:05:33.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":59990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 146,762 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (100,658 shares), July 1, 2027 (30,488 shares) and July 1, 2028 (15,616 shares)."}],"balance_after":228503,"source":{"system":"sec-edgar","filing":"0001395064-26-000130","document":"wk-form4_1777370731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000130/wk-form4_1777370731.xml","form_type":"4"}},{"id":798709,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24043,"kind":"person","name":"Kim Julie So-Young","position":1,"cik":"0001977732","reported_name":"Kim Julie So-Young","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO - Elect"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:04:57.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":105416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 256,372 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (175,526 shares), July 1, 2027 (52,218 shares) and July 1, 2028 (28,628 shares)."}],"balance_after":430145,"source":{"system":"sec-edgar","filing":"0001395064-26-000128","document":"wk-form4_1777370695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000128/wk-form4_1777370695.xml","form_type":"4"}},{"id":798708,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24042,"kind":"person","name":"Platford Giles Richard","position":1,"cik":"0001977620","reported_name":"Platford Giles Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, IBU"}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:04:17.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":72124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 166,744 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (116,762 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares)."}],"balance_after":297363,"source":{"system":"sec-edgar","filing":"0001395064-26-000126","document":"wk-form4_1777370655.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000126/wk-form4_1777370655.xml","form_type":"4"}},{"id":798707,"issuer":{"id":2662,"kind":"organization","name":"TAKEDA PHARMACEUTICAL CO LTD","symbol":"TAK"},"owners":[{"id":24046,"kind":"person","name":"Pignagnoli Agosti Marcello","position":1,"cik":"0001977817","reported_name":"Pignagnoli Agosti Marcello","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head, Strat. & Port. Dev."}}],"security":"American Depositary Shares","published_at":"2026-04-28T10:02:49.000Z","date":"2026-04-27","kind":"grant","planned":false,"acquired":true,"shares":27740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones.  On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 81,590 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one American Depositary Share.  The RSUs vest on the following schedule: July 1, 2026 (52,250 shares), July 1, 2027 (19,798 shares) and July 1, 2028 (9,542 shares)."}],"balance_after":172348,"source":{"system":"sec-edgar","filing":"0001395064-26-000124","document":"wk-form4_1777370567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1395064/000139506426000124/wk-form4_1777370567.xml","form_type":"4"}}]}